Is iNtRON Biotechnology, stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, iNtRON Biotechnology, pays dividends. Last time was Tuesday 16th of April 2024 where the investors holding the stock on Wednesday 27th of December 2023 were paid KRW100 per share. Over the last 1 times between 2023 and 2023, iNtRON Biotechnology, has paid KRW100 with an average of KRW100 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for iNtRON Biotechnology, 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was KRW12 200, you would have made a loss of KRW-6 460.00 per share or -52.95%
Yes, the average daily trading liquidity for iNtRON Biotechnology, is KRW150 917 thousand. You should therefore be able to get in and out of your positions relatively fast.
iNtRON Biotechnology, has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 13.76, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for iNtRON Biotechnology, to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.